In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD

Danae A. Delivanis, Victor M. Montori

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)JC11
JournalAnnals of internal medicine
Volume162
Issue number8
DOIs
StatePublished - Apr 21 2015

ASJC Scopus subject areas

  • Internal Medicine

Cite this